ARCHIVES

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

This article is from The Cancer Letter archive.

Vol. 18 No. 44 | November 13, 1992

Download PDF Visit The Full Archive

Related Articles

Hey Doc, Wanna Score Some Leucovorin? Drugs Available at 80 Times the Price

October 14, 2011

Court Forces CPSC To Reopen Carcinogen Policy

January 19, 1979

In Brief: ACS Seeking Candidate for Holleb Replacement; NCI To Recruit AD For Biological Carcinogenesis

March 13, 1987

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

March 28, 2003

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014